Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody. Saxena R, Bushey RT, Campa MJ, Gottlin EB, et al. J Immunol 2024;212:1589-1601.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saxena R, Bushey RT, Campa MJ, Gottlin EB, et al. Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody. J Immunol 2024;212:1589-1601.
PMID: 38558134